Security key
31189P102
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)
CUSIP: 31189P102
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 109,140,532
- Total 13F value
- $519,540,682
- Share change
- -3,202,435
- Put/Call ratio
- 484%
- SEC-reported price per share
- $4.76
- Number of holders
- 183
- Value change
- -$18,388,551
- Number of buys
- 90
- Number of sells
- 80
- Shares outstanding
- 122,342,805
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
183
Top holders
10
FATE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2023
Previous quarter: Q1 2023
FATE THERAPEUTICS INC SEC filings
FATE THERAPEUTICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 31189P102
Recent filing periods:
Ownership snapshot
Top reported holders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
STATE STREET CORP
Disclosed value leader
STATE STREET CORP
Comparable rows
15/15
Latest evidence
31 Mar 2023
13F
Lead comparable stake: 12%
Showing 1-6 of 15 holder rows.
Quick read
STATE STREET CORP leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens STATE STREET CORP's linked filing trail.
Comparable ownership
Top 5
STATE STREET CORP
12%
Redmile Group, LLC
11%
BlackRock Finance, Inc.
9.4%
VANGUARD GROUP INC
9%
Bellevue Group AG
4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| STATE STREET CORP |
13F
Company
|
12%
|
$84,531,479
14,830,084 shares
|
— | 31 Mar 2023 |
| Redmile Group, LLC |
13F
Company
|
11%
|
$73,856,165
12,957,222 shares
|
— | 31 Mar 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
9.4%
|
$65,414,585
11,476,243 shares
|
— | 31 Mar 2023 |
| VANGUARD GROUP INC |
13F
Company
|
9%
|
$62,477,397
10,960,947 shares
|
— | 31 Mar 2023 |
| Bellevue Group AG |
13F
Company
|
4%
|
$27,677,940
4,855,779 shares
|
— | 31 Mar 2023 |
| JOHNSON & JOHNSON |
13F
Company
|
2.8%
|
$19,260,665
3,379,064 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
183
Shares
109,140,532
Rows available
183
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
177
Q2 2023 holders
183
Holder diff
6
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend